Shares of Trump Media, the owner of social networking site Truth Social, jumped 5 per cent at the opening bell on Friday after the first US presidential debate, with some investors believing it could become a bigger mouthpiece for the former president if he is re-elected.
President Joe Biden and former President Donald Trump clashed on Thursday evening on topics including abortion, immigration and the January 6, 2021 attack on the US Capitol.
Biden’s performance was largely seen as uneven, particularly early on. He tried repeatedly to confront Trump, who countered Biden’s criticism by leaning into falsehoods about the economy, illegal immigration and his role in the January 6 insurrection.
Citi analysts said on Friday there may be increased interest in Trump Media and Technology based on news headlines following the debate.
Shares of Trump Media and Technology have been buffeted during Trump’s run for president and swung wildly a day after Trump’s conviction in his hush money trial
Posts in category Business Standard
Shares of Trump Media and Technology up after first presidential debate (28-06-2024)
Markets see best monthly advance since Dec amid optimism around new govt (28-06-2024)
The gains come amid the background of strong economic data and optimism around the functioning of the new government
G-sec yields settle flat as foreign inflows underwhelmed investors (28-06-2024)
The 10-year benchmark bond yield inched up to 7.02 per cent during the day as traders sold their securities at a profit
Sebi raises basic demat account limit to Rs 10 lakh to boost participation (28-06-2024)
To boost participation of small investors in the securities market, Sebi on Friday increased the threshold for the basic service demat account to Rs 10 lakh from the current Rs 2 lakh.
The new guidelines will come into force from September 1, the Securities and Exchange Board of India (Sebi) said in a circular.
Increasing the limit of securities’ value held in the Basic Services Demat Account (BSDA) will encourage small investors to trade in the stock market and ensure their financial inclusion.
A basic service demat account, or BSDA, is a more basic version of a regular demat account. The facility was introduced by markets regulator Sebi in 2012 to reduce the burden of demat charges on investors with small portfolios.
On eligibility for BSDA, Sebi said an individual is eligible for a BSDA if he/she meets certain criteria such as the investor has only one demat account as the sole or first holder, has only one BSDA in his name across all depositories and the value of securities in
Orchid Pharma partners with Cipla to launch antibiotic drug – Cefepime-Enmetazobactam in India (28-06-2024)
Orchid Pharma announced the launch of its new drug – Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications.
Bharat Electronics secures orders worth Rs 3,653 cr (28-06-2024)
Bharat Electronics (BEL), has signed a contract valued at Rs.3,172 crore with Armoured Vehicles Nigam (AVNL) on 28 June 2024, at AVNL Headquarters in Chennai. The project entails the supply and installation of an advanced, indigenously designed and developed Sighting and Fire Control System (FCS) for the upgrade of BMP 2/2K Tanks of the Indian Army, along with a comprehensive Engineering Support Package.
Tide Water Oil Co. appoints Sourav Ganguly as brand ambassador of Veedol (28-06-2024)
Powered by Capital Market – Live News
eMudhra announces acquisition of New Jersey-based TWO95 International Inc. (28-06-2024)
TWO95 International Inc (TWO95) is based in New Jersey, USA. TWO95 has been engaged in technology solutions and services relating to digital transformation and has been in operations since 2009 with a focus on Healthcare, Utilities, Financial Services and Government. The revenue from digital transformation and cyber security services during the year ended December 31, 2023 amounted to USD 7.6 million.
Blue Cloud Softech Solutions forays into affordable healthcare space (28-06-2024)
Deploys its flagship Healthcare AIOT Product – ‘Truhealthz’ in ESI Primary Healthcare Centres in Assam State
Zydus and Dr Reddy’s ink licensing agreement to co-market Pertuzumab in India (28-06-2024)
Zydus Lifesciences and Dr. Reddy’s Laboratories announced the execution of a licensing agreement to co-market Pertuzumab biosimilar in India.